Anand Kumar Pandey

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Hyaluronic Acid

High Efficiency

Angiotensin Converting Enzyme

Coronavirus Disease

Top Venues

Advances in cell and gene therapy

Drug development and industrial pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Anand Kumar Pandey, Shalja Verma
In silico structural inhibition of ACE-2 binding site of SARS-CoV-2 and SARS-CoV-2 omicron spike protein by lectin antiviral dyad system to treat COVID-19. Drug development and industrial pharmacy 48 (10) (2022)
Shalja Verma, Anand Kumar Pandey
Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis. 3 Biotech 11 (2) (2021)
Anand Kumar Pandey, Shalja Verma
An in silico analysis of effective siRNAs against COVID-19 by targeting the leader sequence of SARS-CoV-2. Advances in cell and gene therapy (2021)